Home / Inspections / 649602

FDA Inspection 649602 — BioGenetics Corporation

BioGenetics Corporation — FEI 3001236618

The FDA completed an inspection of BioGenetics Corporation on February 18, 2010 in Mountainside, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 18, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Mountainside, NJ (United States)

Facility

Other inspections at this facility

  • 1266180 (NAI Fri Mar 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1218002 (NAI Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1111175 (NAI Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1058721 (NAI Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 985822 (NAI Fri Aug 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources